Summary & Overview
CPT 87255: Viral Identification by Cell Impact Analysis
CPT code 87255 represents a laboratory virology procedure used to identify a virus by observing how it affects and damages cells, using methods other than immunologic assays or evaluation of cytopathic effect. This code captures specialized virology testing performed in clinical or hospital laboratory settings and is relevant for laboratories, hospital billing teams, and payers that cover advanced diagnostic virology.
Key payers in national coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the test, typical sites of service, and the role of this code in laboratory billing. The summary highlights common modifiers associated with the service and notes when input data is not provided.
This publication also outlines what readers can expect regarding benchmarks and policy context: an overview of reimbursement considerations, common billing practices for specialized virology testing, and where to find related procedural and coding guidance. Data not available in the input is clearly indicated where applicable. The content is intended for a national audience of laboratory administrators, billing professionals, and policy analysts seeking a practical briefing on CPT code 87255 and its clinical and billing implications.
Billing Code Overview
CPT code 87255 describes a laboratory test in which a lab analyst identifies a virus using methods other than immunologic assays or evaluation of cytopathic effect, focusing on how the virus impacts and damages cells. This procedure involves direct observation and analysis of viral effects on cultured cells or similar preparations.
-
Service type: Viral identification by cell impact/damage observation (non-immunologic, non-cytopathic-effect evaluation)
-
Typical site of service: Clinical laboratory or hospital laboratory setting where virology culture and microscopy are performed
Clinical & Coding Specifications
Clinical Context
A middle-aged adult presents to an outpatient infectious disease laboratory with symptoms of an acute viral illness such as fever, malaise, and respiratory or enteric symptoms. A clinical specimen (e.g., nasopharyngeal swab, stool, or tissue culture) is sent to the virology lab for identification of an etiologic virus using non-immunologic methods that evaluate viral effects on cultured cells (cytopathic effect) and/or alternative molecular/virus identification techniques described by the test method. The lab analyst receives the specimen, documents specimen integrity and labeling, inoculates appropriate cell cultures or performs other specified non-immunologic viral identification methods, incubates and monitors cultures for cytopathic changes, and performs confirmatory testing (e.g., molecular sequencing or PCR-based assays if part of the technique) to identify the viral species or strain. Results are reported to the ordering clinician, such as an infectious disease specialist, pediatrician, hospitalist, or primary care provider, for clinical correlation and management.
Typical site of service: Hospital clinical virology laboratory, reference laboratory, or academic medical center virology lab.
Typical patient scenario: An adult with worsening cough and hypoxia after outpatient treatment; a nasopharyngeal swab is submitted for viral identification to guide antiviral therapy and infection control. The lab performs culture-based observation of cytopathic effect and molecular confirmation consistent with the described methodology.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|